Deliver the
Power Within

Discover how absorbed radiation dose to tumor maximizes necrosis without compromising patient safety <sup>3-6, 13</sup> <div data-url="https://staging.btg-im.com/CMSModules/Content/CMSDesk/Edit/edit.aspx?nodeid=11118&culture=en-US" id="link64_adl_tabid" style="display:none;">1342</div>

Click to discover more
Deliver the<br />
<span class="orange">Power Within</span>
<div data-url="https://staging.btg-im.com/CMSModules/Content/CMSDesk/Edit/edit.aspx?nodeid=11118&culture=en-US" id="link64_adl_tabid" style="display:none;">1341</div>

BTG BETA

Stop Exposing Yourself to Unnecessary Radiation

Learn more
<img alt="BTG BETA" src="~/getattachment/d4c27e76-1b5f-4f6c-8d19-9efffaec05ea/BTG-TS-BETA-logo-v3a.png.aspx" style="margin: 0;" title="BTG BETA" />

SimplicityTM

Simplicit<sup>90</sup>Y<sup>™</sup> is customised, easy-to-use dosimetry software developed for improving <sup>90</sup>Y SIRT workflow and personalising dosimetry.

Click to get started
<img alt="SimplicityTM" src="~/getattachment/cfd4a5ed-331e-4acb-a9ab-b07a643a65e8/Simplicity-TM-Logo.png.aspx" style="margin: 0;" title="SimplicityTM" />

Radiation vs. Embolisation

Some liver cancer treatments work through their embolic properties. TheraSphere utilises radiation as its primary mode of action to destroy tumour tissue.1 The high activity of glass microspheres makes TheraSphere microembolic and preserves normal parenchymal flow since fewer microspheres are needed to achieve the desired absorbed dose.1,3,5,7,11,45


Absorbed Dose Matters

High absorbed dose coverage should be the goal of treatment with radioembolisation. Influenced by the combined effects of microsphere coverage and administered activity, a greater absorbed dose to tumour with TheraSphere™  leads to improved outcomes above certain absorbed dose thresholds without compromising patient safety.1,2,5,6,39,43


Power to Personalize

TheraSphere® offers the flexibility to optimize absorbed dose to the tumor to meet individual patient treatment goals in both the curative and palliative settings. This enables clinical utility for downstaging, bridge to transplant, radiation segmentectomy and portal vein thrombosis.8,9,40,44


TheraSphere

 

TheraSphere® yttrium-90 glass microspheres deliver a targeted radiation dose to the tumour whilst minimising exposure to healthy tissue with mild to moderate side effects.15